TissueTech raises $10M for regenerative medicine businesses

08/23/2013 | MassDevice.com (Boston)

TissueTech has secured $10 million in financing from River Cities Capital Funds and Ballast Point Ventures. The Doral, Fla.-based company will use the money to support research and development as well as fund the commercialization of regenerative medicine products developed by its Amniox Medical and Bio-Tissue units.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Operations - GBS
Mayo Clinic
MN
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC